loadpatents
Patent applications and USPTO patent grants for Sala; Michal.The latest application filed is for "3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator".
Patent | Date |
---|---|
Small molecule inhibitors of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases Grant 11,427,590 - Slusher , et al. August 30, 2 | 2022-08-30 |
3'3'-cyclic Dinucleotide Analogue Comprising A Cyclopentanyl Modified Nucleotide As Sting Modulator App 20220160746 - BIRKUS; Gabriel ;   et al. | 2022-05-26 |
Small Molecule Inhibitors Of Neutral Sphingomyelinase 2 (nsmase2) For The Treatment Of Neurodegenerative Diseases App 20200190089 - Slusher; Barbara ;   et al. | 2020-06-18 |
2'3'-cyclic Dinucleotides Comprising Carbocyclic Nucleotide App 20190359645 - Birkus; Gabriel ;   et al. | 2019-11-28 |
GAK modulators Grant 9,518,066 - Herdewijn , et al. December 13, 2 | 2016-12-13 |
Novel Gak Modulators App 20160122364 - Herdewijn; Piet ;   et al. | 2016-05-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.